Point-of-care magnesium monitoring in athletes: a physiological framework for exercise-related arrhythmic vulnerability
摘要
To summarize physiological mechanisms linking exercise-induced magnesium (Mg2⁺) imbalance to electrophysiological instability in athletes, discuss limitations of serum-based assessment, and propose a conceptual framework for rapid point-of-care magnesium monitoring.
Data sourcesPeer-reviewed evidence from exercise physiology, sports medicine, cardiovascular electrophysiology, and biosensing/wearable-technology literature indexed in PubMed, Scopus, and Web of Science.
Study selectionStudies addressing magnesium loss during exercise (sweat and renal excretion), intracellular Mg2⁺ physiology, repolarization dynamics (including QT modulation), arrhythmogenic mechanisms, and analytic approaches for rapid or wearable electrolyte assessment.
Data extractionKey findings were synthesized regarding Mg2⁺ homeostasis, limitations of conventional biomarkers, feasibility of point-of-care monitoring, and implications for athlete physiological monitoring.
Data synthesisIntense exercise may promote transient Mg2⁺ fluctuations, potentially affecting intracellular availability while serum Mg2⁺ remains within normal limits. Transient Mg2⁺ depletion may influence cardiac repolarization dynamics and contribute to electrophysiological vulnerability during intense exertion. Current screening strategies primarily identify structural or baseline electrical abnormalities and do not capture acute metabolic–electrolyte vulnerability during exertion. Emerging minimally invasive and wearable biosensors may enable rapid Mg2⁺ assessment and support broader physiological monitoring strategies in athletic settings.
ConclusionsIntegrating rapid Mg2⁺ monitoring into athlete physiological assessment frameworks may complement existing screening approaches by providing additional insight into acute metabolic and electrolyte-related stress during training and competition.
Validation studies assessing analytic accuracy, correlation with intracellular markers, and prospective field implementation are required for clinical translation.